Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

Mylan Institutional

manufacturer

70/100

Mylan Institutional is a manufacturer that makes prescription drugs. pharmaranks independently rates 5 of its products, with a composite rating of 3.5 out of 5 based on FDA regulatory (recall-safety) data.

Rated against independent sources·Last updated August 18, 2026·How we rate

Products (5)

Rx70/100

palonosetron hydrochloride

Palonosetron Hydrochloride

(16 data points)
Price variesView
Rx70/100

rimso-50

Dimethyl Sulfoxide

(16 data points)
Price variesView
Rx70/100

sulfamylon

Mafenide Acetate

(16 data points)
Price variesView
Rx70/100

ultiva

Remifentanil Hydrochloride

(16 data points)
Price variesView
Rx68/100

duraclon

Clonidine Hydrochloride

(16 data points)
~$1.05 /30View

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

Frequently asked questions

What does Mylan Institutional make?

Mylan Institutional makes prescription drugs. pharmaranks independently rates 5 of its products — see the full list below.

How is Mylan Institutional rated?

pharmaranks gives Mylan Institutional a composite rating of 3.5 out of 5, based on FDA regulatory (recall-safety) data across its products. See the source breakdown on this page.